Prestige Biologics (Korea) Market Value

334970 Stock  KRW 5,260  60.00  1.13%   
Prestige Biologics' market value is the price at which a share of Prestige Biologics trades on a public exchange. It measures the collective expectations of Prestige Biologics Co investors about its performance. Prestige Biologics is trading at 5260.00 as of the 27th of November 2024, a 1.13% down since the beginning of the trading day. The stock's open price was 5320.0.
With this module, you can estimate the performance of a buy and hold strategy of Prestige Biologics Co and determine expected loss or profit from investing in Prestige Biologics over a given investment horizon. Check out Prestige Biologics Correlation, Prestige Biologics Volatility and Prestige Biologics Alpha and Beta module to complement your research on Prestige Biologics.
Symbol

Please note, there is a significant difference between Prestige Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Prestige Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prestige Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Prestige Biologics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Prestige Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Prestige Biologics.
0.00
10/28/2024
No Change 0.00  0.0 
In 30 days
11/27/2024
0.00
If you would invest  0.00  in Prestige Biologics on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Prestige Biologics Co or generate 0.0% return on investment in Prestige Biologics over 30 days. Prestige Biologics is related to or competes with DC Media, ChipsMedia, Insung Information, Nasmedia, and SM Entertainment. Prestige Biologics Co., Ltd. specializes in the development and production of biologic agents and biosimilars More

Prestige Biologics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Prestige Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Prestige Biologics Co upside and downside potential and time the market with a certain degree of confidence.

Prestige Biologics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Prestige Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Prestige Biologics' standard deviation. In reality, there are many statistical measures that can use Prestige Biologics historical prices to predict the future Prestige Biologics' volatility.
Hype
Prediction
LowEstimatedHigh
5,2565,2605,264
Details
Intrinsic
Valuation
LowRealHigh
4,8874,8915,786
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Prestige Biologics. Your research has to be compared to or analyzed against Prestige Biologics' peers to derive any actionable benefits. When done correctly, Prestige Biologics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Prestige Biologics.

Prestige Biologics Backtested Returns

Prestige Biologics maintains Sharpe Ratio (i.e., Efficiency) of -0.058, which implies the firm had a -0.058% return per unit of risk over the last 3 months. Prestige Biologics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prestige Biologics' Variance of 13.59, risk adjusted performance of (0.07), and Coefficient Of Variation of (973.00) to confirm the risk estimate we provide. The company holds a Beta of -0.59, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Prestige Biologics are expected to decrease at a much lower rate. During the bear market, Prestige Biologics is likely to outperform the market. At this point, Prestige Biologics has a negative expected return of -0.21%. Please make sure to check Prestige Biologics' coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Prestige Biologics performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.87  

Very good predictability

Prestige Biologics Co has very good predictability. Overlapping area represents the amount of predictability between Prestige Biologics time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Prestige Biologics price movement. The serial correlation of 0.87 indicates that approximately 87.0% of current Prestige Biologics price fluctuation can be explain by its past prices.
Correlation Coefficient0.87
Spearman Rank Test0.87
Residual Average0.0
Price Variance46.7 K

Prestige Biologics lagged returns against current returns

Autocorrelation, which is Prestige Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Prestige Biologics' stock expected returns. We can calculate the autocorrelation of Prestige Biologics returns to help us make a trade decision. For example, suppose you find that Prestige Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Prestige Biologics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Prestige Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Prestige Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Prestige Biologics stock over time.
   Current vs Lagged Prices   
       Timeline  

Prestige Biologics Lagged Returns

When evaluating Prestige Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Prestige Biologics stock have on its future price. Prestige Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Prestige Biologics autocorrelation shows the relationship between Prestige Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in Prestige Biologics Co.
   Regressed Prices   
       Timeline  

Pair Trading with Prestige Biologics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Prestige Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prestige Biologics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Prestige Stock

  0.82326030 Sk BiopharmaceuticalsPairCorr
  0.73298380 ABL BioPairCorr
  0.7144510 Green Cross LabPairCorr

Moving against Prestige Stock

  0.31182360 Cube EntertainmentPairCorr
The ability to find closely correlated positions to Prestige Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Prestige Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Prestige Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Prestige Biologics Co to buy it.
The correlation of Prestige Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Prestige Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Prestige Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Prestige Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Prestige Stock

Prestige Biologics financial ratios help investors to determine whether Prestige Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prestige with respect to the benefits of owning Prestige Biologics security.